To add a bio or update investment portfolio click update information.
Lux Capital: Investment Portfolio & Startup News
Lux Capital
Investment Portfolio


Cambridge Aerospace lands £222m Series C led by DFJ Growth for low-cost drone interceptor missiles
Cambridge Aerospace designs and manufactures low-cost interceptor missiles and supporting air defence hardware, including the Skyhammer interceptor, the Looking Glass radar system and the Nightstar solid rocket motor. Its systems are built for armed forces that need an affordable way to counter one-way attack drones such as Iranian Shahed-style systems.


Agon emerges from stealth with a £22m seed round from VCs to build synthetic battlefields that train AI defence systems
Agon builds synthetic battlefield infrastructure where AI defence systems are designed, trained and refined before they are deployed. Simulated combat environments allow defence companies, AI developers and governments to rehearse scenarios such as countering drone swarms.


CuspAI announces £335m Series B led by Kleiner Perkins and NEA to design new semiconductor, energy and advanced manufacturing materials
CuspAI builds an agentic AI platform, MIRA, that designs new materials to order, running the full cycle from generative design through simulation, synthesis planning and coordinated lab validation. The platform serves industrial and government R&D teams in semiconductors, clean energy and advanced manufacturing, where the materials needed for next-generation products do not yet exist.


1001 raises £22m Series A led by Lux Capital to build AI system for critical infrastructure operators
1001 builds sovereign AI operating systems for operators across critical infrastructure sectors. The systems sit above an operator's existing infrastructure, building a live working model of the operation to predict issues, automate decisions and optimise operations while keeping full local ownership and governance with the client.
- 4(12 months)
- luxcapital.com
More venture news
- 17 Nov 2026

Isomorphic LabsIsomorphic Labs unlocks a £3.8bn Series C round led by Greenoaks and Sequoia Capital to design new medicines with AI
Series CLife Sciences - 11 Nov 2026

FractileFractile raises a £540m Series C from investors including Thrive and Founders Fund to build the chips that AI frontiers run on
Series CDeep Tech - 15 Oct 2026

OMass TherapeuticsOMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform
Series CLife Sciences